Related Experiment Video

Updated: Jul 5, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

The E3 ubiquitin ligase c-Cbl restricts development and functions of hematopoietic stem cells

Chozhavendan Rathinam1, Christine B F Thien, Wallace Y Langdon

  • 1Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut 06520, USA.

Genes & Development
|April 17, 2008
PubMed

Insights

The E3 ubiquitin ligase c-Cbl (casitas B-cell lymphoma) negatively regulates hematopoietic stem cells (HSCs). Deleting c-Cbl enhances HSC function, increasing their pool size and repopulating capacity.

Area of Science:

  • Hematology
  • Molecular Biology
  • Cell Biology

Background:

  • Hematopoietic stem cells (HSCs) are crucial for lifelong blood cell production.
  • Understanding the regulation of HSCs is vital for regenerative medicine and treating blood disorders.

Purpose of the Study:

  • To investigate the role of the E3 ubiquitin ligase c-Cbl (casitas B-cell lymphoma) in regulating HSC development and function.
  • To elucidate the molecular mechanisms by which c-Cbl affects HSCs.

Main Methods:

  • Analysis of HSCs from c-Cbl knockout (c-Cbl(-/-)) mice.
  • Assessment of HSC pool size, proliferation, competence, and repopulating capacity.
  • Mechanistic studies involving thrombopoietin (TPO) signaling and STAT5 phosphorylation.

Main Results:

  • HSCs from c-Cbl(-/-) mice showed an augmented pool size and hyperproliferation.
  • c-Cbl deficiency resulted in enhanced HSC competence and long-term repopulating capacity.
  • c-Cbl(-/-) HSCs exhibited hyperresponsiveness to TPO, with elevated STAT5 phosphorylation and increased c-Myc expression.

Conclusions:

  • The E3 ubiquitin ligase c-Cbl is a novel negative regulator of HSC development and function.
  • c-Cbl deficiency leads to improved HSC properties through enhanced TPO signaling.
  • These findings identify c-Cbl as a potential therapeutic target for modulating HSC behavior.

More Related Videos

Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation11:40

Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation

Published on: October 20, 2014

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells10:25

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells

Published on: August 9, 2019

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
Production of Formed Elements01:34

Production of Formed Elements

Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...